Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288106 · ClinicalTrials.gov registry record
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
A clinical trial, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- 961
- Enrollment target
NCT00288106: Clinical Trial study, sponsored by SWOG Cancer Research Network.
NCT00288106 is a clinical trial that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 961 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00288106 was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- 961 participants
- Enrollment target
Study Summary
RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care. PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing treatment with either finasteride or a placebo on the Prostate Cancer Prevention Trial (PCPT).
Interventions
- OTHER Follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 961 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-05 |
Why NCT00288106 stopped before completion
NCT00288106 is an observational study that tracks outcomes without assigning an intervention. The registered 961 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Follow-up is the first listed.
NCT00288106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00288106 about?
NCT00288106 is a clinical study titled "S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT". RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care. PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing trea...
What is the current status of trial NCT00288106?
This trial is currently terminated. The enrollment target is 961 participants. The study started on 2005-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00288106?
The interventions under investigation include: Follow-up (OTHER).
Who is sponsoring clinical trial NCT00288106?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia